2018 Reed Dynasty Trust sold $1.6M of ARHS
2018 Reed Dynasty Trust sold 127,965 shares of Arhaus, Inc. (ARHS) at an average of $12.63 ($12.02–$13.03, $1.62M total) across 2 trades over 2026-11-03 to 2026-11-04 under a Rule 10b5-1 trading plan.
Arhaus, Inc.
Arhaus is a home furnishings retailer that designs and sources furniture and décor for clients furnishing their homes. Its product range includes indoor and outdoor furniture, bath products, lighting, textiles and décor. The company works with nearly 400 vendors and operates its own upholstery manufacturing facility in North Carolina. It sells through showrooms, eCommerce, catalogs, interior design services and a trade program. As of December 31, 2025, Arhaus operated 107 showrooms in 31 states, including Traditional Showrooms, Design Studios and Arhaus the Loft locations. Arhaus makes money by selling its products directly to consumers and trade customers through its sales channels. Its interior designers offer complimentary, personalized support in showrooms, online and in clients’ homes. Arhaus is headquartered in Boston Heights, Ohio, where its corporate headquarters occupies part of its distribution facilities.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
2018 Reed Dynasty Trust sold 127,965 shares of Arhaus, Inc. (ARHS) at an average of $12.63 ($12.02–$13.03, $1.62M total) across 2 trades over 2026-11-03 to 2026-11-04 under a Rule 10b5-1 trading plan.
Reed John P (CEO and Chairman) sold 147,431 indirectly-held shares of Arhaus, Inc. (ARHS) at an average of $12.63 ($12.02–$13.03, $1.86M total) across 2 trades over 2026-11-03 to 2026-11-04 under a Rule 10b5-1 trading plan.
Arhaus reported Q3 2026 revenue of $368.1 million, missing estimates by 0.7%, and EPS of $0.05, missing by 41.7%. Adjusted EBITDA was $27.39 million, a 14.1% miss. Q4 revenue guidance is $408 million, above estimates. Operating margin fell to 2.7%, while free cash flow margin rose to 25%.
Over the past 7 days, AlphAI's AI scored 10 news stories mentioning ARHS (Arhaus, Inc.). Coverage has been balanced: 4 bullish, 2 neutral, and 4 bearish.
Recent ARHS coverage spans earnings, insider activity and market movers.
In the last 30 days, ARHS insiders filed 4 SEC Form 4 transactions — no purchases and 4 sales ($3.5M). The most active reporter was 2018 Reed Dynasty Trust with 2 filings. 100% of those filings were made under pre-arranged Rule 10b5-1 plans.
Insider sale may signal slight negative sentiment.
The insider sale may create modest selling pressure on ARHS.
The earnings miss may pressure the stock as investors reassess growth expectations.
Earnings beat revenue expectations and raised full-year guidance, likely supporting the stock.
This is a pre-earnings calendar update that can drive positioning into the print and volatility around the release window.
AlphAI scores every news story that mentions ARHS with an AI model for sentiment and relevance, and aggregates insider trades from Arhaus, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
2018 Reed Dynasty Trust sold 127,965 shares of Arhaus, Inc. (ARHS) at an average of $12.63 ($12.02–$13.03, $1.62M total) across 2 trades over 2026-11-03 to 2026-11-04 under a Rule 10b5-1 trading plan.
Reed John P (CEO and Chairman) sold 147,431 indirectly-held shares of Arhaus, Inc. (ARHS) at an average of $12.63 ($12.02–$13.03, $1.86M total) across 2 trades over 2026-11-03 to 2026-11-04 under a Rule 10b5-1 trading plan.
Arhaus reported Q3 2026 revenue of $368.1 million, missing estimates by 0.7%, and EPS of $0.05, missing by 41.7%. Adjusted EBITDA was $27.39 million, a 14.1% miss. Q4 revenue guidance is $408 million, above estimates. Operating margin fell to 2.7%, while free cash flow margin rose to 25%.
Arhaus, Inc. (ARHS) filed an SEC Form 8-K — Results of Operations and Financial Condition. ARHAUS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS BOSTON HEIGHTS, Ohio (November 5, 2026)—Arhaus, Inc. (“Arhaus” or the “Company”) (NASDAQ: ARHS), a premium home furnishing brand known for responsibly sourced, artisan-crafted products and heirloom-quality design, reported third
Arhaus (NASDAQ: ARHS) will release its Q3 2026 results on Nov. 5, 2026, before market open, followed by a conference call at 8:30 a.m. ET. The company, known for premium home furnishings, operates 100+ showrooms in the U.S. and offers an omni-channel shopping experience.
Telsey raised its price target on Arhaus (ARHS) to $12.00, citing demand recovery and strong Q3 2026 expectations. The firm forecasts revenue of $376M, up 9.0% YoY, and EBITDA of $33M. ARHS shares are up 57% in six months but are considered overvalued by InvestingPro. The company reports Q3 results on November 5.
Arhaus reported a 7.4% revenue increase to $384.9M in Q2 2026, beating estimates. Net earnings were $0.28 per share, exceeding forecasts by 72.3%. Gross margin improved to 44.7%, and same-store sales rose 4%. The company expanded to 109 stores. Analysts noted weak long-term growth despite revenue gains, and the retailer maintained its full-year revenue outlook of $1.45B.
Lowe's (NYSE:LOW) reported $25.96B revenue, up 8.3% YoY, missing EPS and revenue guidance. Arhaus (NASDAQ:ARHS) reported $384.9M revenue, up 7.4% YoY, beating estimates. RH (NYSE:RH) reported $922.2M revenue, up 2.6% YoY, also beating estimates. Lowe's stock fell 7.7%, Arhaus rose 42.1%, and RH gained 2.4% post-earnings.
Braze (BRZE) surged 51.2% after a $5.66B acquisition by Salesforce. Amkor (AMKR) rose 7.1% following a $1.3B NVIDIA deal. Oceaneering (OII) dropped 17.5% due to a 26% YoY net income decline. Arhaus (ARHS) gained 2.6% after an analyst upgrade. Silgan (SLGN) increased 5.1% with a $2.3B metal packaging deal.
Washington Trust Bancorp (WASH) rose 5% after beating Q3 2026 estimates. Doximity (DOCS) gained 7.3% following a partnership with Wolters Kluwer. Myriad Genetics (MYGN) surged 22.2% after selling its Prenatal Health unit to Labcorp. Arhaus (ARHS) climbed 6.5% on an upgrade and price target raise. Gartner (IT) increased 4.5% after price target hikes.